1. Home
  2. SNGX vs ULY Comparison

SNGX vs ULY Comparison

Compare SNGX & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.30

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Logo Urgent.ly Inc.

ULY

Urgent.ly Inc.

HOLD

Current Price

$2.30

Market Cap

5.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
ULY
Founded
1987
2013
Country
United States
United States
Employees
N/A
308
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
5.0M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
ULY
Price
$1.30
$2.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$11.50
AVG Volume (30 Days)
195.6K
1.5M
Earning Date
11-07-2025
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$127,932,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$1.74
52 Week High
$6.23
$17.99

Technical Indicators

Market Signals
Indicator
SNGX
ULY
Relative Strength Index (RSI) 40.11 46.22
Support Level $1.35 $2.12
Resistance Level $1.46 $2.50
Average True Range (ATR) 0.07 0.31
MACD -0.00 -0.07
Stochastic Oscillator 11.63 13.00

Price Performance

Historical Comparison
SNGX
ULY

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: